Supreme Court weighs generic drug dispute
Wednesday, October 15, 2014 - 12:02
in Mathematics & Economics
(AP)—The U.S. Supreme Court seems divided as it considers a high-stakes patent dispute between rival pharmaceutical companies over the world's best-selling multiple sclerosis treatment.